WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsson, M.
Right arrow Articles by Bjorklund, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olsson, M.
Right arrow Articles by Bjorklund, A.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 3863-3875, Copyright © 1995 by Society for Neuroscience


ARTICLE

Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

M Olsson, G Nikkhah, C Bentlage and A Bjorklund
Department of Medical Cell Research, University of Lund, Sweden.

Methods for the assessment of akinesia in the unilateral rat Parkinson model have so far been lacking. The experiments reported here evaluate the usefulness of a new "stepping test" to monitor forelimb akinesia in rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the mesencephalic dopamine (DA) system, and to assess the ability of DA- receptor agonists and fetal DA neuron transplants to reverse these deficits. The 6-OHDA lesion induced marked and long-lasting impairments in the initiation of stepping movements with the contralateral paw. Systemic injections of low doses (chosen to be subthreshold for induction of rotation) of the mixed D1 and D2 receptor agonist apomorphine, the D1-selective agonist SKF 38393, and to a lesser extent also the D2-selective agonist quinpirole were effective in reversing these deficits. Similar effects was seen after a subrotational dose of L-dopa, whereas amphetamine had no effect. Fetal nigral transplants, implanted as multiple deposits in the ipsilateral caudate-putamen and substantia nigra, restored initiation of stepping to a similar degree as the DA agonists. Nigral grafts placed in substantia nigra alone were also effective, although the improvement was less pronounced. Apomorphine, at a dose effective in the lesion-only animals, had no additive effect in the grafted rats, whereas amphetamine appeared to further improve stepping in the rats with intranigral transplants. Identical experiments were performed on skilled forelimb use in the so- called staircase test. Interestingly, neither the DA agonist drugs nor the nigral transplants had any effects on the lesion induced deficits in this more complex task. The results show that forelimb stepping is a highly useful test to monitor lesion-/and transplant-induced changes in forelimb akinesia, a behavioral parameter that may be analogous to limb akinesia and gait problems seen in patients with Parkinson's disease.


This article has been cited by other articles:


Home page
BrainHome page
K. Mukhida, M. Hong, G.B. Miles, T. Phillips, B.A. Baghbaderani, M. McLeod, N. Kobayashi, A. Sen, L.A. Behie, R.M. Brownstone, et al.
A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats
Brain, August 1, 2008; 131(8): 2106 - 2126.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Dejean, C. E. Gross, B. Bioulac, and T. Boraud
Dynamic Changes in the Cortex-Basal Ganglia Network After Dopamine Depletion in the Rat
J Neurophysiol, July 1, 2008; 100(1): 385 - 396.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. C. P. Godoy, R. Tarelli, C. C. Ferrari, M. I. Sarchi, and F. J. Pitossi
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Brain, July 1, 2008; 131(7): 1880 - 1894.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. E. O'Keeffe, S. A. Scott, P. Tyers, G. W. O'Keeffe, J. W. Dalley, R. Zufferey, and M. A. Caldwell
Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease
Brain, March 1, 2008; 131(3): 630 - 641.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. Yang, Z.-J. Zhang, M. Oldenburg, M. Ayala, and S.-C. Zhang
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
Stem Cells, January 1, 2008; 26(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Carta, T. Carlsson, D. Kirik, and A. Bjorklund
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Brain, July 1, 2007; 130(7): 1819 - 1833.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Breysse, T. Carlsson, C. Winkler, A. Bjorklund, and D. Kirik
The Functional Impact of the Intrastriatal Dopamine Neuron Grafts in Parkinsonian Rats Is Reduced with Advancing Disease
J. Neurosci., May 30, 2007; 27(22): 5849 - 5856.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Marti, C. Trapella, R. Viaro, and M. Morari
The Nociceptin/Orphanin FQ Receptor Antagonist J-113397 and L-DOPA Additively Attenuate Experimental Parkinsonism through Overinhibition of the Nigrothalamic Pathway
J. Neurosci., February 7, 2007; 27(6): 1297 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. D. Humphries, R. D. Stewart, and K. N. Gurney
A Physiologically Plausible Model of Action Selection and Oscillatory Activity in the Basal Ganglia
J. Neurosci., December 13, 2006; 26(50): 12921 - 12942.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C.-H. Park, J. S. Kang, Y. H. Shin, M.-Y. Chang, S. Chung, H.-C. Koh, M. H. Zhu, S. B. Oh, Y.-S. Lee, G. Panagiotakos, et al.
Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons
FASEB J, December 1, 2006; 20(14): 2553 - 2555.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y.-S. Fu, Y.-C. Cheng, M.-Y. A. Lin, H. Cheng, P.-M. Chu, S.-C. Chou, Y.-H. Shih, M.-H. Ko, and M.-S. Sung
Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton's Jelly to Dopaminergic Neurons In Vitro: Potential Therapeutic Application for Parkinsonism
Stem Cells, January 1, 2006; 24(1): 115 - 124.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Ben-Hur, M. Idelson, H. Khaner, M. Pera, E. Reinhartz, A. Itzik, and B. E. Reubinoff
Transplantation of Human Embryonic Stem Cell-Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats
Stem Cells, December 1, 2004; 22(7): 1246 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E. Keen-Rhinehart, S. P. Kalra, and P. S. Kalra
Leptin-Receptor Gene Transfer into the Arcuate Nucleus of Female Fatty Zucker Rats Using Recombinant Adeno-Associated Viral Vectors Stimulates the Hypothalamo-Pituitary-Gonadal Axis
Biol Reprod, July 1, 2004; 71(1): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Nakagawa, M. Ohgoh, Y. Nishizawa, and H. Ogura
Dopaminergic Agonists and Muscarinic Antagonists Improve Lateralization in Hemiparkinsonian Rats in a Novel Exploratory Y-Maze
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-W. Shim, H.-C. Koh, M.-Y. Chang, E. Roh, C.-Y. Choi, Y. J. Oh, H. Son, Y.-S. Lee, L. Studer, and S.-H. Lee
Enhanced In Vitro Midbrain Dopamine Neuron Differentiation, Dopaminergic Function, Neurite Outgrowth, and 1-Methyl-4-Phenylpyridium Resistance in Mouse Embryonic Stem Cells Overexpressing Bcl-XL
J. Neurosci., January 28, 2004; 24(4): 843 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Vergara-Aragon, C. L. R. Gonzalez, and I. Q. Whishaw
A Novel Skilled-Reaching Impairment in Paw Supination on the "Good" Side of the Hemi-Parkinson Rat Improved with Rehabilitation
J. Neurosci., January 15, 2003; 23(2): 579 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. N. Ruskin, D. A. Bergstrom, and J. R. Walters
Nigrostriatal Lesion and Dopamine Agonists Affect Firing Patterns of Rodent Entopeduncular Nucleus Neurons
J Neurophysiol, July 1, 2002; 88(1): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Nikkhah, G. Falkenstein, and C. Rosenthal
Restorative Plasticity of Dopamine Neuronal Transplants Depends on the Degree of Hemispheric Dominance
J. Neurosci., August 15, 2001; 21(16): 6252 - 6263.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Y. Tseng, F. Kasanetz, L. Kargieman, L. A. Riquelme, and M. G. Murer
Cortical Slow Oscillatory Activity Is Reflected in the Membrane Potential and Spike Trains of Striatal Neurons in Rats with Chronic Nigrostriatal Lesions
J. Neurosci., August 15, 2001; 21(16): 6430 - 6439.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. L. Tillerson, A. D. Cohen, J. Philhower, G. W. Miller, M. J. Zigmond, and T. Schallert
Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine
J. Neurosci., June 15, 2001; 21(12): 4427 - 4435.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Mukhida, K. A. Baker, D. Sadi, and I. Mendez
Enhancement of Sensorimotor Behavioral Recovery in Hemiparkinsonian Rats with Intrastriatal, Intranigral, and Intrasubthalamic Nucleus Dopaminergic Transplants
J. Neurosci., May 15, 2001; 21(10): 3521 - 3530.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Kirik, C. Winkler, and A. Bjorklund
Growth and Functional Efficacy of Intrastriatal Nigral Transplants Depend on the Extent of Nigrostriatal Degeneration
J. Neurosci., April 15, 2001; 21(8): 2889 - 2896.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Kirik, C. Rosenblad, A. Bjorklund, and R. J. Mandel
Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal System
J. Neurosci., June 15, 2000; 20(12): 4686 - 4700.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Winkler, H. Sauer, C. S. Lee, and A. Bjorklund
Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
J. Neurosci., November 15, 1996; 16(22): 7206 - 7215.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Mendez, D. Sadi, and M. Hong
Reconstruction of the Nigrostriatal Pathway by Simultaneous Intrastriatal and Intranigral Dopaminergic Transplants
J. Neurosci., November 15, 1996; 16(22): 7216 - 7227.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Bencsics, S. R. Wachtel, S. Milstien, K. Hatakeyama, J. B. Becker, and U. J. Kang
Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis of L-DOPA by Primary Fibroblasts
J. Neurosci., July 15, 1996; 16(14): 4449 - 4456.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-